Assessment of Motor Unit Potentials Duration as the Biomarker of DT-DEC01 Cell Therapy Efficacy in Duchenne Muscular Dystrophy Patients up to 12  Months After Systemic–Intraosseous Administration

This study confirmed EMG as a reliable and objective biomarker of functional assessment in DMD patients after intraosseous administratio n of the novel DT-DEC01 therapy.
Source: Archivum Immunologiae et Therapiae Experimentalis - Category: Allergy & Immunology Source Type: research